531 related articles for article (PubMed ID: 7925194)
1. Use of tissue disposition data from rats and dogs to determine species differences in input parameters for a physiological model for perchloroethylene.
Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
Environ Res; 1994 Oct; 67(1):54-67. PubMed ID: 7925194
[TBL] [Abstract][Full Text] [Related]
2. Physiologically based pharmacokinetic model useful in prediction of the influence of species, dose, and exposure route on perchloroethylene pharmacokinetics.
Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
J Toxicol Environ Health; 1995 Mar; 44(3):301-17. PubMed ID: 7897693
[TBL] [Abstract][Full Text] [Related]
3. Use of a physiologically based model to predict systemic uptake and respiratory elimination of perchloroethylene.
Dallas CE; Muralidhara S; Chen XM; Ramanathan R; Varkonyi P; Gallo JM; Bruckner JV
Toxicol Appl Pharmacol; 1994 Sep; 128(1):60-8. PubMed ID: 8079355
[TBL] [Abstract][Full Text] [Related]
4. Development of a physiologically based pharmacokinetic model for perchloroethylene using tissue concentration-time data.
Dallas CE; Chen XM; O'Barr K; Muralidhara S; Varkonyi P; Bruckner JV
Toxicol Appl Pharmacol; 1994 Sep; 128(1):50-9. PubMed ID: 8079354
[TBL] [Abstract][Full Text] [Related]
5. Computer simulation of the lactational transfer of tetrachloroethylene in rats using a physiologically based model.
Byczkowski JZ; Kinkead ER; Leahy HF; Randall GM; Fisher JW
Toxicol Appl Pharmacol; 1994 Apr; 125(2):228-36. PubMed ID: 8171430
[TBL] [Abstract][Full Text] [Related]
6. Schedule-controlled operant behavior of rats following oral administration of perchloroethylene: time course and relationship to blood and brain solvent levels.
Warren DA; Reigle TG; Muralidhara S; Dallas CE
J Toxicol Environ Health; 1996 Mar; 47(4):345-62. PubMed ID: 8600288
[TBL] [Abstract][Full Text] [Related]
7. Uptake, distribution, and elimination of carbon tetrachloride in rat tissues following inhalation and ingestion exposures.
Sanzgiri UY; Srivatsan V; Muralidhara S; Dallas CE; Bruckner JV
Toxicol Appl Pharmacol; 1997 Mar; 143(1):120-9. PubMed ID: 9073600
[TBL] [Abstract][Full Text] [Related]
8. Physiologically based pharmacokinetic modeling of cyclotrimethylenetrinitramine in male rats.
Krishnan K; Crouse LC; Bazar MA; Major MA; Reddy G
J Appl Toxicol; 2009 Oct; 29(7):629-37. PubMed ID: 19629953
[TBL] [Abstract][Full Text] [Related]
9. Tissue dosimetry expansion and cross-validation of rat and mouse physiologically based pharmacokinetic models for trichloroethylene.
Keys DA; Bruckner JV; Muralidhara S; Fisher JW
Toxicol Sci; 2003 Nov; 76(1):35-50. PubMed ID: 12915716
[TBL] [Abstract][Full Text] [Related]
10. A physiologically based pharmacokinetic model for endosulfan in the male Sprague-Dawley rats.
Chan MP; Morisawa S; Nakayama A; Kawamoto Y; Sugimoto M; Yoneda M
Environ Toxicol; 2006 Oct; 21(5):464-78. PubMed ID: 16944508
[TBL] [Abstract][Full Text] [Related]
11. Toxicokinetics of inhaled propylene in mouse, rat, and human.
Filser JG; Schmidbauer R; Rampf F; Baur CM; Pütz C; Csanády GA
Toxicol Appl Pharmacol; 2000 Nov; 169(1):40-51. PubMed ID: 11076695
[TBL] [Abstract][Full Text] [Related]
12. Bayesian analysis of a physiologically based pharmacokinetic model for perchloroethylene in humans.
Qiu J; Chien YC; Bruckner JV; Fisher JW
J Toxicol Environ Health A; 2010; 73(1):74-91. PubMed ID: 19953421
[TBL] [Abstract][Full Text] [Related]
13. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA
Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513
[TBL] [Abstract][Full Text] [Related]
14. Kinetic modeling of beta-chloroprene metabolism: II. The application of physiologically based modeling for cancer dose response analysis.
Himmelstein MW; Carpenter SC; Evans MV; Hinderliter PM; Kenyon EM
Toxicol Sci; 2004 May; 79(1):28-37. PubMed ID: 14976335
[TBL] [Abstract][Full Text] [Related]
15. Acute perchloroethylene exposure alters rat visual-evoked potentials in relation to brain concentrations.
Boyes WK; Bercegeay M; Oshiro WM; Krantz QT; Kenyon EM; Bushnell PJ; Benignus VA
Toxicol Sci; 2009 Mar; 108(1):159-72. PubMed ID: 19098276
[TBL] [Abstract][Full Text] [Related]
16. Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses.
Meno-Tetang GM; Li H; Mis S; Pyszczynski N; Heining P; Lowe P; Jusko WJ
Drug Metab Dispos; 2006 Sep; 34(9):1480-7. PubMed ID: 16751263
[TBL] [Abstract][Full Text] [Related]
17. A physiologically based pharmacokinetic model for 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in the rat: tissue distribution and CYP1A induction.
Kedderis LB; Mills JJ; Andersen ME; Birnbaum LS
Toxicol Appl Pharmacol; 1993 Jul; 121(1):87-98. PubMed ID: 8337704
[TBL] [Abstract][Full Text] [Related]
18. The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene.
Covington TR; Robinan Gentry P; Van Landingham CB; Andersen ME; Kester JE; Clewell HJ
Regul Toxicol Pharmacol; 2007 Feb; 47(1):1-18. PubMed ID: 16901594
[TBL] [Abstract][Full Text] [Related]
19. Use of in vitro data for construction of a physiologically based pharmacokinetic model for naphthalene in rats and mice to probe species differences.
Quick DJ; Shuler ML
Biotechnol Prog; 1999; 15(3):540-55. PubMed ID: 10356275
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
Timchalk C; Nolan RJ
Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]